{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90","record_version":"public-1:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-23T04:48:42.447898+00:00","published_at":"2026-10-23T04:48:42.447898+00:00","section":"events","data":{"state":"PUBLISHED","derivation_version":"alpha-governance-event-derivation-v2","events":[{"event_id":"alpha:event:transition:1u3gkdbik571t","event_type":"EXECUTIVE_APPOINTED","effective_at":"2026-04-27","detected_at":"2026-10-23T04:48:42.447898+00:00","subject_ids":["alpha:person:brendan-hannah","alpha:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90"],"caused_claim_ids":["alpha:claim:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90:leadership_role:13"],"evidence_ids":["alpha:projection-evidence:document:288330e3c016595ff3f1f8b1102b956bc748a7ea9dde332e5f978bdf37ad3870"],"summary":"Brendan Hannah executive of Quince Therapeutics, Inc., effective 2026-04-27.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:17xrivq1f61noe","event_type":"EXECUTIVE_APPOINTED","effective_at":"2026-04-27","detected_at":"2026-10-23T04:48:42.447898+00:00","subject_ids":["alpha:person:charles-ryan-ph-d","alpha:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90"],"caused_claim_ids":["alpha:claim:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90:leadership_role:14"],"evidence_ids":["alpha:projection-evidence:document:80a4e3c051aa373698a25063dc08119102e86bc37e05a8d50ed10f4160a2c5aa"],"summary":"Charles Ryan, Ph.D. executive of Quince Therapeutics, Inc., effective 2026-04-27.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:6kg97hzu46az","event_type":"CEO_CHANGED","effective_at":"2026-04-27","detected_at":"2026-10-23T04:48:42.447898+00:00","subject_ids":["alpha:person:dirk-thye-m-d","alpha:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90"],"caused_claim_ids":["alpha:claim:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90:leadership_role:15"],"evidence_ids":["alpha:projection-evidence:document:4b820e7c20f71968195b0e22da3bdfc92d844f5d78686ecfddb6d0be5cb244d1"],"summary":"Dirk Thye, M.D. executive of Quince Therapeutics, Inc., effective 2026-04-27.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:ezd1v1qp3s0r","event_type":"DIRECTOR_APPOINTED","effective_at":"2024-01-01","detected_at":"2026-10-23T04:48:42.447898+00:00","subject_ids":["alpha:person:rajiv-patni-m-d","alpha:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90"],"caused_claim_ids":["alpha:claim:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:084591a613955543458ff8a80e42b939045d0491ce326aa151fe40702684f99e"],"summary":"Rajiv Patni, M.D. seat on Quince Therapeutics, Inc., effective 2024-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:geddlhu1ywcp","event_type":"DIRECTOR_APPOINTED","effective_at":"2023-01-01","detected_at":"2026-10-23T04:48:42.447898+00:00","subject_ids":["alpha:person:luca-benatti-ph-d","alpha:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90"],"caused_claim_ids":["alpha:claim:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:084591a613955543458ff8a80e42b939045d0491ce326aa151fe40702684f99e"],"summary":"Luca Benatti, Ph.D. seat on Quince Therapeutics, Inc., effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:tu7djerm5wmu","event_type":"DIRECTOR_APPOINTED","effective_at":"2022-01-01","detected_at":"2026-10-23T04:48:42.447898+00:00","subject_ids":["alpha:person:dirk-thye-m-d","alpha:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90"],"caused_claim_ids":["alpha:claim:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:084591a613955543458ff8a80e42b939045d0491ce326aa151fe40702684f99e"],"summary":"Dirk Thye, M.D. seat on Quince Therapeutics, Inc., effective 2022-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:zs6anh4ohsyh","event_type":"DIRECTOR_APPOINTED","effective_at":"2022-01-01","detected_at":"2026-10-23T04:48:42.447898+00:00","subject_ids":["alpha:person:june-bray","alpha:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90"],"caused_claim_ids":["alpha:claim:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:084591a613955543458ff8a80e42b939045d0491ce326aa151fe40702684f99e"],"summary":"June Bray seat on Quince Therapeutics, Inc., effective 2022-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:mvpxw282vroa","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2022-01-01","detected_at":"2026-10-23T04:48:42.447898+00:00","subject_ids":["alpha:person:june-bray","alpha:committee:quince-therapeutics-inc:audit"],"caused_claim_ids":["alpha:claim:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90:committee_record:16"],"evidence_ids":["alpha:projection-evidence:7c13d5fbb017fbac7ebaeefdcfeff0dca268e7e79864357f8a18c3072dd9412d"],"summary":"June Bray member of Audit, effective 2022-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:l7k01g1gtp8qs","event_type":"DIRECTOR_APPOINTED","effective_at":"2019-01-01","detected_at":"2026-10-23T04:48:42.447898+00:00","subject_ids":["alpha:person:christopher-j-senner-2","alpha:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90"],"caused_claim_ids":["alpha:claim:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90:leadership_role:5"],"evidence_ids":["alpha:projection-evidence:document:084591a613955543458ff8a80e42b939045d0491ce326aa151fe40702684f99e"],"summary":"Christopher J. Senner seat on Quince Therapeutics, Inc., effective 2019-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:32rvzo13u1xfa","event_type":"DIRECTOR_APPOINTED","effective_at":"2019-01-01","detected_at":"2026-10-23T04:48:42.447898+00:00","subject_ids":["alpha:person:una-ryan-obe-ph-d","alpha:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90"],"caused_claim_ids":["alpha:claim:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90:leadership_role:12"],"evidence_ids":["alpha:projection-evidence:document:084591a613955543458ff8a80e42b939045d0491ce326aa151fe40702684f99e"],"summary":"Una Ryan, OBE, Ph.D. seat on Quince Therapeutics, Inc., effective 2019-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:191753x1ibp5pj","event_type":"DIRECTOR_APPOINTED","effective_at":"2015-01-01","detected_at":"2026-10-23T04:48:42.447898+00:00","subject_ids":["alpha:person:david-a-lamond","alpha:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90"],"caused_claim_ids":["alpha:claim:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:084591a613955543458ff8a80e42b939045d0491ce326aa151fe40702684f99e"],"summary":"David A. Lamond seat on Quince Therapeutics, Inc., effective 2015-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:12z8ue06hpy30","event_type":"DIRECTOR_APPOINTED","effective_at":"2015-01-01","detected_at":"2026-10-23T04:48:42.447898+00:00","subject_ids":["alpha:person:margaret-a-mcloughlin-ph-d","alpha:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90"],"caused_claim_ids":["alpha:claim:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:084591a613955543458ff8a80e42b939045d0491ce326aa151fe40702684f99e"],"summary":"Margaret A. McLoughlin, Ph.D. seat on Quince Therapeutics, Inc., effective 2015-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:na9sql1k89rrb","event_type":"COMMITTEE_CREATED","effective_at":"2015-01-01","detected_at":"2026-10-23T04:48:42.447898+00:00","subject_ids":["alpha:committee:quince-therapeutics-inc:compensation-chair-nominating-and-governance-chair","alpha:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90"],"caused_claim_ids":["alpha:claim:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:084591a613955543458ff8a80e42b939045d0491ce326aa151fe40702684f99e"],"summary":"Compensation · Chair; Nominating and Governance · Chair committee of Quince Therapeutics, Inc., effective 2015-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:irftparey4dw","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2015-01-01","detected_at":"2026-10-23T04:48:42.447898+00:00","subject_ids":["alpha:person:david-a-lamond","alpha:committee:quince-therapeutics-inc:compensation-chair-nominating-and-governance-chair"],"caused_claim_ids":["alpha:claim:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:084591a613955543458ff8a80e42b939045d0491ce326aa151fe40702684f99e"],"summary":"David A. Lamond member of Compensation · Chair; Nominating and Governance · Chair, effective 2015-01-01.","derivation":"temporal_relationship_change"}]},"claims":[{"id":"alpha:claim:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90:leadership_role:5","subject_id":"alpha:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:christopher-j-senner-2","object_label":"Christopher J. Senner","object_source_name_forms":[],"value":"Christopher J. Senner: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:christopher-j-senner-2","name":"Christopher J. Senner"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2019-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2019-01-01","valid_to":null,"recorded_at":"2026-10-23T04:48:42.447898+00:00","sources":[{"id":"alpha:projection-evidence:document:084591a613955543458ff8a80e42b939045d0491ce326aa151fe40702684f99e","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Quince Therapeutics, Inc. DEF 14A 2025-04-23","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000166277425000025/qncx-20250423.htm","source_date":"2025-04-23","retrieved_at":"2026-04-28T23:51:01.281+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-23","effective_from":"2019-01-01","effective_until":null,"observed_at":"2026-10-23T04:48:42.447898+00:00","reviewed_at":"2026-10-23T04:48:42.447898+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90:leadership_role:6","subject_id":"alpha:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:david-a-lamond","object_label":"David A. Lamond","object_source_name_forms":[],"value":"David A. Lamond: Director, Compensation · Chair; Nominating and Governance · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:david-a-lamond","name":"David A. Lamond"},"title":"Director","role_category":"director","committee":"Compensation · Chair; Nominating and Governance · Chair","is_board_chair":false,"is_independent":true,"start_date":"2015-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2015-01-01","valid_to":null,"recorded_at":"2026-10-23T04:48:42.447898+00:00","sources":[{"id":"alpha:projection-evidence:document:084591a613955543458ff8a80e42b939045d0491ce326aa151fe40702684f99e","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Quince Therapeutics, Inc. DEF 14A 2025-04-23","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000166277425000025/qncx-20250423.htm","source_date":"2025-04-23","retrieved_at":"2026-04-28T23:51:01.281+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-23","effective_from":"2015-01-01","effective_until":null,"observed_at":"2026-10-23T04:48:42.447898+00:00","reviewed_at":"2026-10-23T04:48:42.447898+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90:leadership_role:7","subject_id":"alpha:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:dirk-thye-m-d","object_label":"Dirk Thye, M.D.","object_source_name_forms":[],"value":"Dirk Thye, M.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:dirk-thye-m-d","name":"Dirk Thye, M.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2022-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2022-01-01","valid_to":null,"recorded_at":"2026-10-23T04:48:42.447898+00:00","sources":[{"id":"alpha:projection-evidence:document:084591a613955543458ff8a80e42b939045d0491ce326aa151fe40702684f99e","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Quince Therapeutics, Inc. DEF 14A 2025-04-23","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000166277425000025/qncx-20250423.htm","source_date":"2025-04-23","retrieved_at":"2026-04-28T23:51:01.281+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-23","effective_from":"2022-01-01","effective_until":null,"observed_at":"2026-10-23T04:48:42.447898+00:00","reviewed_at":"2026-10-23T04:48:42.447898+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90:leadership_role:8","subject_id":"alpha:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:june-bray","object_label":"June Bray","object_source_name_forms":[],"value":"June Bray: Director, Audit","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:june-bray","name":"June Bray"},"title":"Director","role_category":"director","committee":"Audit","is_board_chair":false,"is_independent":true,"start_date":"2022-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2022-01-01","valid_to":null,"recorded_at":"2026-10-23T04:48:42.447898+00:00","sources":[{"id":"alpha:projection-evidence:document:084591a613955543458ff8a80e42b939045d0491ce326aa151fe40702684f99e","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Quince Therapeutics, Inc. DEF 14A 2025-04-23","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000166277425000025/qncx-20250423.htm","source_date":"2025-04-23","retrieved_at":"2026-04-28T23:51:01.281+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-23","effective_from":"2022-01-01","effective_until":null,"observed_at":"2026-10-23T04:48:42.447898+00:00","reviewed_at":"2026-10-23T04:48:42.447898+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90:leadership_role:9","subject_id":"alpha:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:luca-benatti-ph-d","object_label":"Luca Benatti, Ph.D.","object_source_name_forms":[],"value":"Luca Benatti, Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:luca-benatti-ph-d","name":"Luca Benatti, Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2023-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2023-01-01","valid_to":null,"recorded_at":"2026-10-23T04:48:42.447898+00:00","sources":[{"id":"alpha:projection-evidence:document:084591a613955543458ff8a80e42b939045d0491ce326aa151fe40702684f99e","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Quince Therapeutics, Inc. DEF 14A 2025-04-23","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000166277425000025/qncx-20250423.htm","source_date":"2025-04-23","retrieved_at":"2026-04-28T23:51:01.281+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-23","effective_from":"2023-01-01","effective_until":null,"observed_at":"2026-10-23T04:48:42.447898+00:00","reviewed_at":"2026-10-23T04:48:42.447898+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90:leadership_role:10","subject_id":"alpha:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:margaret-a-mcloughlin-ph-d","object_label":"Margaret A. McLoughlin, Ph.D.","object_source_name_forms":[],"value":"Margaret A. McLoughlin, Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:margaret-a-mcloughlin-ph-d","name":"Margaret A. McLoughlin, Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2015-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2015-01-01","valid_to":null,"recorded_at":"2026-10-23T04:48:42.447898+00:00","sources":[{"id":"alpha:projection-evidence:document:084591a613955543458ff8a80e42b939045d0491ce326aa151fe40702684f99e","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Quince Therapeutics, Inc. DEF 14A 2025-04-23","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000166277425000025/qncx-20250423.htm","source_date":"2025-04-23","retrieved_at":"2026-04-28T23:51:01.281+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-23","effective_from":"2015-01-01","effective_until":null,"observed_at":"2026-10-23T04:48:42.447898+00:00","reviewed_at":"2026-10-23T04:48:42.447898+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90:leadership_role:11","subject_id":"alpha:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:rajiv-patni-m-d","object_label":"Rajiv Patni, M.D.","object_source_name_forms":[],"value":"Rajiv Patni, M.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:rajiv-patni-m-d","name":"Rajiv Patni, M.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2024-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2024-01-01","valid_to":null,"recorded_at":"2026-10-23T04:48:42.447898+00:00","sources":[{"id":"alpha:projection-evidence:document:084591a613955543458ff8a80e42b939045d0491ce326aa151fe40702684f99e","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Quince Therapeutics, Inc. DEF 14A 2025-04-23","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000166277425000025/qncx-20250423.htm","source_date":"2025-04-23","retrieved_at":"2026-04-28T23:51:01.281+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-23","effective_from":"2024-01-01","effective_until":null,"observed_at":"2026-10-23T04:48:42.447898+00:00","reviewed_at":"2026-10-23T04:48:42.447898+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90:leadership_role:12","subject_id":"alpha:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:una-ryan-obe-ph-d","object_label":"Una Ryan, OBE, Ph.D.","object_source_name_forms":[],"value":"Una Ryan, OBE, Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:una-ryan-obe-ph-d","name":"Una Ryan, OBE, Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2019-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2019-01-01","valid_to":null,"recorded_at":"2026-10-23T04:48:42.447898+00:00","sources":[{"id":"alpha:projection-evidence:document:084591a613955543458ff8a80e42b939045d0491ce326aa151fe40702684f99e","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Quince Therapeutics, Inc. DEF 14A 2025-04-23","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000166277425000025/qncx-20250423.htm","source_date":"2025-04-23","retrieved_at":"2026-04-28T23:51:01.281+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-23","effective_from":"2019-01-01","effective_until":null,"observed_at":"2026-10-23T04:48:42.447898+00:00","reviewed_at":"2026-10-23T04:48:42.447898+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90:leadership_role:13","subject_id":"alpha:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:brendan-hannah","object_label":"Brendan Hannah","object_source_name_forms":[],"value":"Brendan Hannah: Chief Operating Officer, Chief Business Officer, and Chief Compliance Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:brendan-hannah","name":"Brendan Hannah"},"title":"Chief Operating Officer, Chief Business Officer, and Chief Compliance Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-27","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-27","valid_to":null,"recorded_at":"2026-10-23T04:48:42.447898+00:00","sources":[{"id":"alpha:projection-evidence:document:288330e3c016595ff3f1f8b1102b956bc748a7ea9dde332e5f978bdf37ad3870","identity_scope":"source_document_reference","source_type":"sec_filing","title":"QNCX DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000119312526182255/qncx-20260424.htm","source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-05-16T07:20:33.884819+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-27T00:00:00+00:00","effective_from":"2026-04-27","effective_until":null,"observed_at":"2026-10-23T04:48:42.447898+00:00","reviewed_at":"2026-10-23T04:48:42.447898+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90:leadership_role:14","subject_id":"alpha:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:charles-ryan-ph-d","object_label":"Charles Ryan, Ph.D.","object_source_name_forms":[],"value":"Charles Ryan, Ph.D.: President","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:charles-ryan-ph-d","name":"Charles Ryan, Ph.D."},"title":"President","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-27","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-27","valid_to":null,"recorded_at":"2026-10-23T04:48:42.447898+00:00","sources":[{"id":"alpha:projection-evidence:document:80a4e3c051aa373698a25063dc08119102e86bc37e05a8d50ed10f4160a2c5aa","identity_scope":"source_document_reference","source_type":"sec_filing","title":"QNCX DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000119312526182255/qncx-20260424.htm","source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-05-16T07:20:33.410852+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-27T00:00:00+00:00","effective_from":"2026-04-27","effective_until":null,"observed_at":"2026-10-23T04:48:42.447898+00:00","reviewed_at":"2026-10-23T04:48:42.447898+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90:leadership_role:15","subject_id":"alpha:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:dirk-thye-m-d","object_label":"Dirk Thye, M.D.","object_source_name_forms":[],"value":"Dirk Thye, M.D.: Chief Executive Officer, Chief Medical Officer and Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:dirk-thye-m-d","name":"Dirk Thye, M.D."},"title":"Chief Executive Officer, Chief Medical Officer and Director","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-27","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-27","valid_to":null,"recorded_at":"2026-10-23T04:48:42.447898+00:00","sources":[{"id":"alpha:projection-evidence:document:4b820e7c20f71968195b0e22da3bdfc92d844f5d78686ecfddb6d0be5cb244d1","identity_scope":"source_document_reference","source_type":"sec_filing","title":"QNCX DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000119312526182255/qncx-20260424.htm","source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-05-16T07:20:32.960705+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-27T00:00:00+00:00","effective_from":"2026-04-27","effective_until":null,"observed_at":"2026-10-23T04:48:42.447898+00:00","reviewed_at":"2026-10-23T04:48:42.447898+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90:committee_record:16","subject_id":"alpha:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Audit: Chair Christopher J. Senner; Members Christopher J. Senner (Chair); June Bray","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Audit","canonical_type":"audit","chair":"Christopher J. Senner","members":[{"display_name":"Christopher J. Senner","person_slug":"christopher-j-senner","is_chair":true},{"display_name":"June Bray","person_slug":"june-bray","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-23T04:48:42.447898+00:00","sources":[{"id":"alpha:projection-evidence:7c13d5fbb017fbac7ebaeefdcfeff0dca268e7e79864357f8a18c3072dd9412d","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1662774/000166277425000025/qncx-20250423.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-23T04:48:42.447898+00:00","reviewed_at":"2026-10-23T04:48:42.447898+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:084591a613955543458ff8a80e42b939045d0491ce326aa151fe40702684f99e","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Quince Therapeutics, Inc. DEF 14A 2025-04-23","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000166277425000025/qncx-20250423.htm","source_date":"2025-04-23","retrieved_at":"2026-04-28T23:51:01.281+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:288330e3c016595ff3f1f8b1102b956bc748a7ea9dde332e5f978bdf37ad3870","identity_scope":"source_document_reference","source_type":"sec_filing","title":"QNCX DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000119312526182255/qncx-20260424.htm","source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-05-16T07:20:33.884819+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:80a4e3c051aa373698a25063dc08119102e86bc37e05a8d50ed10f4160a2c5aa","identity_scope":"source_document_reference","source_type":"sec_filing","title":"QNCX DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000119312526182255/qncx-20260424.htm","source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-05-16T07:20:33.410852+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:4b820e7c20f71968195b0e22da3bdfc92d844f5d78686ecfddb6d0be5cb244d1","identity_scope":"source_document_reference","source_type":"sec_filing","title":"QNCX DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000119312526182255/qncx-20260424.htm","source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-05-16T07:20:32.960705+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:7c13d5fbb017fbac7ebaeefdcfeff0dca268e7e79864357f8a18c3072dd9412d","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1662774/000166277425000025/qncx-20250423.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.844,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.882,"cross_source_agreement":0.75,"temporal_completeness":0.733},"diagnostics":{"published_claims":22,"factual_claims":22,"claims_with_linked_evidence":22,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":15,"temporal_claims_with_valid_from":11,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-23T04:48:42.447898+00:00","observed_at":"2026-10-23T04:48:42.447898+00:00","reviewed_at":"2026-10-23T04:48:42.447898+00:00","verified_at":"2026-10-23T04:48:42.447898+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":22,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/quince-therapeutics-inc/events","section":"events","href":"https://registry.alpha.ac/api/public/companies/quince-therapeutics-inc?format=record&section=events","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}